We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+11.16%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$294M
AUM Growth
+$47M
Cap. Flow
+$52.7M
Cap. Flow %
17.92%
Top 10 Hldgs %
26.72%
Holding
84
New
21
Increased
28
Reduced
22
Closed
9

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$5.68M
2
GILD icon
Gilead Sciences
GILD
+$5.11M
3
AET
Aetna Inc
AET
+$4.9M
4
BSX icon
Boston Scientific
BSX
+$4.74M
5
KND
Kindred Healthcare
KND
+$3.25M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$6.31M
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$6.08M
3
SYK icon
Stryker
SYK
+$5.14M
4
LPNT
LifePoint Health, Inc.
LPNT
+$3.19M
5
AMGN icon
Amgen
AMGN
+$3.1M

Sector Composition

Rank Sector Weight
1 Healthcare 84.8%
2 Financials 1.81%
3 Industrials 0.84%
4 Energy 0.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNH icon
26
UnitedHealth
UNH
$365B
$4.73M 1.61%
40,000
-2,702
-6% -$300K
CAH icon
27
Cardinal Health
CAH
$56.3B
$4.47M 1.52%
49,500
+10,000
+25% +$861K
MNK
28
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$4.43M 1.51%
35,000
-10,000
-22% -$1.14M
BMRN icon
29
BioMarin Pharmaceuticals
BMRN
$13.5B
$4.36M 1.48%
35,000
+5,200
+17% +$551K
BMY icon
30
Bristol-Myers Squibb
BMY
$130B
$4.35M 1.48%
67,500
-11,700
-15% -$732K
CVS icon
31
CVS Health
CVS
$120B
$4.13M 1.4%
40,000
+5,300
+15% +$536K
JAZZ icon
32
Jazz Pharmaceuticals
JAZZ
$16.1B
$3.89M 1.32%
22,500
+2,700
+14% +$463K
ELV icon
33
Elevance Health
ELV
$84.7B
$3.86M 1.31%
25,000
+16,440
+192% +$2.34M
KND
34
DELISTED
Kindred Healthcare
KND
$3.81M 1.3%
+160,000
New +$3.25M
ENDP
35
DELISTED
Endo International plc
ENDP
$3.59M 1.22%
40,000
+5,300
+15% +$443K
CNC icon
36
Centene
CNC
$32.1B
$3.54M 1.2%
100,000
-42,000
-30% -$1.26M
ALXN
37
DELISTED
Alexion Pharmaceuticals
ALXN
$3.47M 1.18%
20,000
+200
+1% +$36.2K
TRNX
38
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$3.41M 1.16%
130,000
-18,700
-13% -$474K
MOH icon
39
Molina Healthcare
MOH
$10.2B
$3.37M 1.15%
50,100
-4,100
-8% -$237K
MDVN
40
DELISTED
MEDIVATION, INC.
MDVN
$3.23M 1.1%
50,000
-9,800
-16% -$561K
AMGN icon
41
Amgen
AMGN
$224B
$3.2M 1.09%
20,000
-19,700
-50% -$3.1M
INCY icon
42
Incyte
INCY
$24.5B
$3.18M 1.08%
34,700
– –
SCAI
43
DELISTED
Surgical Care Affiliates, Inc.
SCAI
$3.11M 1.06%
90,713
-3,287
-3% -$109K
A icon
44
Agilent Technologies
A
$42.2B
$2.91M 0.99%
+70,000
New +$2.83M
GEN
45
DELISTED
Genesis Healthcare, Inc.
GEN
$2.85M 0.97%
+400,000
New +$3.02M
AMED
46
DELISTED
Amedisys
AMED
$2.82M 0.96%
105,200
+10,000
+11% +$282K
STJ
47
DELISTED
St Jude Medical
STJ
$2.8M 0.95%
+42,775
New +$2.84M
ILMN icon
48
Illumina
ILMN
$29.1B
$2.75M 0.93%
15,214
– –
ACH
49
Accendra Health
ACH
$96.5M
$2.72M 0.93%
80,400
+30,500
+61% +$1.06M
FEIC
50
DELISTED
FEI COMPANY
FEIC
$2.67M 0.91%
+35,000
New +$2.8M
1
2
3 4

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return

Sivik Global Healthcare's Q1 2015 Portfolio in Review

As of Q1 2015, Sivik Global Healthcare held 84 positions worth $294M, up 19% from $247M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Sivik Global Healthcare deployed $52.7M of net new capital in Q1 2015, opening 21 new positions and adding to 28 existing holdings. Its largest new stake was Medtronic: 75,000 shares worth $5.85M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 90% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Amgen, an estimated $3.1M trimmed.

  • Sivik Global Healthcare's largest Q1 2015 buy was Medtronic: 75,000 shares worth $5.85M.
  • Sivik Global Healthcare added most to Gilead Sciences in Q1 2015, an estimated $5.11M increase.
  • Sivik Global Healthcare's biggest Q1 2015 reduction was Amgen, cutting an estimated $3.1M.
  • Sivik Global Healthcare fully exited Allergan Inc in Q1 2015, selling an estimated $6.31M.
  • Sivik Global Healthcare's ten largest holdings make up 27% of its $294M portfolio in Q1 2015.
  • Sivik Global Healthcare opened 21 new positions and closed 9 in Q1 2015.
  • Sivik Global Healthcare's portfolio value rose 19% quarter-over-quarter to $294M.

Based on Sivik Global Healthcare's 13F filing for Q1 2015, filed 1 Apr 2015.